Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended				173 Months Ended
	Mar. 31, 2014		Mar. 31, 2013		Mar. 31, 2014
NET REVENUES
Sales			$ 3,140		$ 464,295
Royalties					645,180
TOTAL NET REVENUE			3,140		1,109,475
COST OF SALES			2,710		431,741
GROSS PROFIT			430		677,734
OPERATING EXPENSES
General and administrative	124,761		83,867		2,416,346
Legal and accounting	132,195		112,437		2,146,929
Patent costs					65,000
Payroll expenses	1,074,680	[1]	567,500	[1]	14,004,172	[1]
Research and development	845,729		137,500		2,357,705
Sales and marketing	51,436		47,231		5,327,899
Total operating expenses	2,228,801		948,535		26,318,051
LOSS BEFORE OTHER INCOME (EXPENSE)	(2,228,801)		(948,105)		(25,640,317)
OTHER INCOME (EXPENSE)
Interest income					63,664
Interest expense	(10,907)		(41,241)		(2,329,164)
Loss on extinguishment of debt					(1,221,875)
Change in fair value of warrants	(890,000)		(11,921,510)		(1,494,209)
Change in fair value of embedded derivative liability	(300,000)				(100,000)
Fair value of warrants in excess of consideration for convertible preferred stock			(2,995,791)		(2,995,791)
Gain on debt forgiveness					340,352
Gain on disposition of assets					4,722
TOTAL OTHER INCOME (EXPENSE)	(1,200,907)		(14,958,542)		(7,732,301)
LOSS BEFORE INCOME TAX BENEFIT	(3,429,708)		(15,906,647)		(33,372,618)
INCOME TAX BENEFIT					(165,000)
NET LOSS	(3,429,708)		(15,906,647)		(33,207,618)
Less: Deemed dividend distribution			(1,000,000)		(1,000,000)
NET LOSS APPLICABLE TO COMMON STOCKHOLDERS	$ (3,429,708)		$ (16,906,647)		$ (34,207,618)
NET LOSS PER COMMON SHARE
BASIC (in dollars per share)	$ (0.01)		$ (0.07)
DILUTED (in dollars per share)	$ (0.01)		$ (0.07)
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING
BASIC (in shares)	297,571,958		227,124,683
DILUTED (in shares)	297,571,958		227,124,683

[1] includes share based compensation of $9,360,091 cumulative, $740,954 for the three months ended March 31, 2014 and $332,599 for the three months ended March 31, 2013